LAE-32

Lysergic acid ethylamide (also known as LAE-32, LAE, and d-ethyllysergamide) is a semisynthetic psychedelic substance of the lysergamide class that is structurally similar to LSD. LAE-32 is one of the least known and least researched psychedelic substances. The pharmacology of LAE-32 is complex^{[citation needed]}, but it acts primarily by binding to serotonin receptors in the brain, much like LSD and other serotonergic psychedelics.^{[citation needed]}

Chemical Nomenclature

Common names

LAE-32, LAE

Substitutive name

d-Lysergic acid ethylamide

Systematic name

N-ethyl-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

Class Membership

Psychoactive class

Psychedelic

Chemical class

Lysergamide

Routes of Administration

WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section.

⇣ Sublingual
Dosage
Threshold	0.5-1.5"-1.5" can not be assigned to a declared number type with value 0.5. mg
Duration

DISCLAIMER: PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy.

Interactions

Cannabis

Amphetamines

Cocaine

Tramadol

Summary sheet: LAE-32

The CIA and Project MKULTRA Findings

LAE-32 was experimented with by the CIA as part of Project MKULTRA. It was reported to create a condition similar to that of schizophrenia in mentally healthy individuals, characterized by indifference and depersonalization. While it was reported that, when used on schizophrenics, it created a condition that allowed the patients to become indifferent to their hallucinations and cease hallucinatory excitation.